Hints and tips:
...Yet companies worldwide effectively do that, repeatedly....
...AbbVie Sector: pharmaceuticals / HQ: Chicago, US Key stat: Received regulatory clearance for its $63bn deal for Allergan in May....
...• Mikael Dolsten, global president for worldwide research and development, will also assume oversight of the Chief Medical Officer’s role....
...Chartwatch Patent ploy Allergan’s transfer of patent rights for its lucrative eye medicine, Restasis, to the Native American Mohawk tribe — thereby giving the drug “sovereign immunity” and protection from...
...Allergan recently acquired another smaller Nash-focused drugmaker, Arkana, for $50m....
...Allergan will pay AstraZeneca $250m upfront for an exclusive, worldwide licence to develop and commercialise MEDI2070, a treatment that is currently undergoing clinical trials for moderate to severe Crohn...
...Glaucoma is expected to affect more than 80m people worldwide by 2020 and has the potential to become one of the leading causes of blindness....
...Drugmaker Pfizer has insisted that its $160bn takeover of Allergan will not be thwarted by political opposition, amid criticism of a deal that will cost the US Treasury billions of dollars in future tax...
...Here’s a look at the 10 biggest deals that have been pulled worldwide this year:...
...Dr Mikael Dolsten, president of worldwide research and development at Pfizer, said he was aware of the unease but that the combined company would occupy a “sweet spot” in R&D....
...They in effect removed the tax advantages of US-based Pfizer’s purchase of Ireland-domiciled Allergan. In the third, it was the Chinese government that forced Anbang ’s hand....
...Millions of people worldwide have lost some or all of their sight through diseases ranging from the common age-related macular degeneration (AMD) and diabetic retinopathy to a host of rare genetic conditions...
...At the centre of Pfizer’s decision to move its tax base is the distinctive US system of worldwide taxation, which means that companies pay extra tax when they repatriate foreign profits, giving them an incentive...
...The numbers that add up to 2014 Business $66bn Value of Botox-maker Allergan implied by Activis’s friendly takeover, the largest pharma deal of the year £297m Fine paid by GlaxoSmithKline after it was...
...Last year it brought in revenues of €5.7bn as Sanofi responded to the rising incidence of diabetes worldwide....
...The chairman of Reliance Industries, operator of the world’s biggest oil refinery complex, added almost $800 million to his wealth yesterday… Gautam Adani was the second-biggest gainer worldwide as he added...
...The incident has raised further questions about the safety of its cars, just weeks after the company recalled several million cars worldwide....
...Fears of a slowing economy also fed through to advertising and recruitment company Monster Worldwide, which tumbled 4.9 per cent to $42.45....
International Edition